Co-Authors
This is a "connection" page, showing publications co-authored by Alan Wu and Chak-Sing Lau.
Connection Strength
0.112
-
Development and validation of risk prediction models for COVID-19 positivity in a hospital setting. Int J Infect Dis. 2020 Dec; 101:74-82.
Score: 0.056
-
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 05 30; 395(10238):1695-1704.
Score: 0.055